IP Library Granted Patent US 10,072,078
Granted Patent B2
US 10,072,078 · App. 14/437,889 · Granted Sep 11, 2018

M971 chimeric antigen receptors

Inventors: Rimas J. Orentas (Washington, DC); Ira H. Pastan (Potomac, MD); Dimiter S. Dimitrov (Frederick, MD); Crystal L. Mackall (Bethesda, MD)
Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
C07K16/2803A61K39/0011C07K16/3061C12N5/0638A61K2039/5156A61K2039/5158C07K2319/03C07K2319/74C12N2501/505C12N2501/599C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,072,078
App. No.
14/437,889
Granted
Sep 11, 2018
Kind
B2
Abstract

The invention provides a chimeric antigen receptor (CAR) comprising an antigen binding domain comprising SEQ ID NOs: 1-6, a transmembrane domain, and an intracellular T cell signaling domain. Nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions relating to the CARs are disclosed. Methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal are also disclosed.

Claims (18)

1. A chimeric antigen receptor (CAR) comprising an antigen binding domain comprising the amino acid sequences of SEQ ID NOs: 1-6, a transmembrane domain, and an intracellular T cell signaling domain.

2. The CAR according to claim 1 , wherein the antigen binding domain comprises a light chain variable region comprising an amino acid sequence comprising SEQ ID NO: 7.

3. The CAR according to claim 1 , wherein the antigen binding domain comprises a heavy chain variable region comprising an amino acid sequence comprising SEQ ID NO: 8.

4. The CAR according to claim 1 , wherein the antigen binding domain comprises an amino acid sequence comprising SEQ ID NO: 9.

5. The CAR according to claim 1 , wherein the antigen binding domain comprises a linker comprising SEQ ID NO: 11.

6. The CAR according to claim 1 , further comprising a leader sequence comprising SEQ ID NO: 10.

7. The CAR according to claim 1 , wherein the transmembrane domain comprises i) a transmembrane portion of a CD8 and/or ii) a transmembrane portion of a CD28.

8. The CAR according to claim 1 , wherein the transmembrane domain comprises an amino acid sequence comprising SEQ ID NO: 12 or 18 and/or an amino acid sequence comprising SEQ ID NO: 15.

9. The CAR according to claim 1 , wherein the intracellular T cell signaling domain comprises one or more of i) an intracellular signaling portion of a CD28, ii) an intracellular signaling portion of a CD137, and iii) an intracellular signaling portion of a CD3 zeta.

10. The CAR according to claim 1 , wherein the intracellular T cell signaling domain comprises an amino acid sequence comprising SEQ ID NO: 16 or 19.

11. The CAR according to claim 1 , wherein the intracellular T cell signaling domain comprises an amino acid sequence comprising SEQ ID NO: 13 or 20.

12. The CAR according to claim 1 , wherein the intracellular T cell signaling domain comprises an amino acid sequence comprising SEQ ID NO: 14, 17 or 21.

13. The CAR according to claim 1 , comprising an amino acid sequence comprising any one of SEQ ID NOs: 22-24.

14. The CAR according to claim 1 , wherein the intracellular T cell signaling domain comprises an intracellular signaling portion of a CD28 or comprises an intracellular signaling portion of a CD137 and wherein the CAR does not comprise an intracellular signaling portion of both a CD28 and a CD137.

15. The CAR according to claim 14 , wherein the CAR does not comprise an intracellular signaling domain of more than one T cell costimulatory molecule.

16. The CAR of claim 1 , comprising and amino acid sequence comprising SEQ ID NO: 22.

17. The CAR of claim 1 , comprising and amino acid sequence comprising SEQ ID NO: 23.

18. The CAR of claim 1 , comprising and amino acid sequence comprising SEQ ID NO: 24.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2015
From: ORENTAS, RIMAS J.; PASTAN, IRA H.; DIMITROV, DIMITER S.; MACKALL, CRYSTAL L.
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 035985/0353 →
Continuity (2)
Provisional Application 61717960 · Oct 24, 2012
Related Publication 20150299317A1 · Oct 22, 2015
Cited By (2)
US 12,466,867 US 12,473,336